Northern Swan Holdings
Alternative MedicineUnited States11-50 Employees
We are an opportunistic, New York-based investment firm focused on early and late-stage investments. We pursue opportunities in heavily regulated industries globally.
Growing Investment Portfolio Northern Swan Holdings has successfully closed a Series D financing round raising nearly 100 million dollars, indicating a strong investor confidence and significant capital for expansion. This financial backdrop offers opportunities to provide specialized financial services, investment technology solutions, or strategic advisory support for its continued growth.
Strategic Industry Focus The company's emphasis on heavily regulated industries such as cannabis and alternative medicine positions it as a key player in emerging markets. Business development efforts can target companies operating within these sectors, offering compliance solutions, regulatory consulting, or market expansion services.
International Expansion Northern Swan has invested in European entities like Cansativa GmbH, suggesting an active interest in international markets. Sales opportunities include international trade services, cross-border legal consulting, or localization solutions to support their global strategy.
Thought Leadership & Networking The company has enhanced its advisory board with prominent political figures such as former Senate Majority Leader Tom Daschle and Congressman Joseph Crowley, highlighting a strategic push to influence policy and industry standards. Opportunities exist to collaborate on policy advisory, industry research, or leadership training programs.
Emerging Market Engagement With a focus on the European cannabis market and heavily regulated sectors, Northern Swan is well-positioned to engage with innovative companies seeking to navigate complex regulatory landscapes. Business opportunities include regulatory compliance solutions, market entry consulting, and specialized technology platforms for industry-specific needs.
| Northern Swan Holdings Email Formats | Percentage |
| First@northernswan.com | 39% |
| First.Last@northernswan.com | 13% |
| Last@northernswan.com | 9% |
| First@northernswan.com | 39% |
Alternative MedicineUnited States11-50 Employees
We are an opportunistic, New York-based investment firm focused on early and late-stage investments. We pursue opportunities in heavily regulated industries globally.
Northern Swan Holdings has raised a total of $58M of funding over 2 rounds. Their latest funding round was raised on Apr 10, 2019 in the amount of $58M.
Northern Swan Holdings's revenue is estimated to be in the range of $1M
Northern Swan Holdings has raised a total of $58M of funding over 2 rounds. Their latest funding round was raised on Apr 10, 2019 in the amount of $58M.
Northern Swan Holdings's revenue is estimated to be in the range of $1M